The illness sends tens of thousands of babies to the hospital each year. If approved, the new injection would be the first broadly available prevention tool.
When Meany's daughters got their injections in January 2015, they were the first babies in the world to receive it, according to AstraZeneca.
Progress didn't come until two decades later. In 1998, the FDA OK'd a monoclonal antibody for premature and high-risk babies. But Domachowske said changing medical guidelines since then have severely limited eligibility for this treatment, and, he said, its efficacy wasn't great. That's where the research had been stuck for years until 2014, when Domachowske attended a medical conference in Argentina. A featured speaker dropped a massive discovery that a lot of RSV research focused on the wrong protein.
Not too long later, he injected Meany's daughters with an improved, longer-lasting monoclonal antibody that protects babies through an RSV season with one shot.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Flu, RSV on Decline, but COVID Deaths PersistRespiratory illness levels in the U.S. have declined so much in recent weeks that they are approaching numbers usually seen during non-flu season.
Les mer »
Could a Heart Medication Stop Violent Crimes From Happening?While it’s used to treat hypertension, it could also help treat escalating tensions too.
Les mer »
City of Plano public works department working long hours to treat roadsIf not for the street crews, the unsung heroes of this winter storm, getting around at all would be next to impossible.
Les mer »
Semi-living 'cyborg cells' could treat cancer, suggests new studyAccording to the University of California, Davis researchers, cyborg cells may serve as environmental and health instruments.
Les mer »
Addiction psychologist warns Dr. Phil audience smartphone addiction ‘more challenging to treat than heroin’Dr. Phil spoke with digital addiction expert Dr. Nicholas Kardaras about how to battle reliance on smartphones among youth, comparing it to a drug problem.
Les mer »